Related references
Note: Only part of the references are listed.Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Kamran Ghoreschi et al.
LANCET (2021)
Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes
Carolin Christmann et al.
FRONTIERS IN IMMUNOLOGY (2021)
IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation
Pascale Zwicky et al.
SCIENCE IMMUNOLOGY (2021)
Second-Strand Synthesis-Based Massively Parallel scRNA-Seq Reveals Cellular States and Molecular Features of Human Inflammatory Skin Pathologies
Travis K. Hughes et al.
IMMUNITY (2020)
Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept
Carrie Brodmerkel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Interleukin-22 and Its Correlation with Disease Activity in Plaque Psoriasis
Bartlomiej Wawrzycki et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2019)
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
Thomas Vogl et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms
Marijana Kovacic et al.
CELLULAR ONCOLOGY (2018)
Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
Fatemeh Shabani et al.
INFLAMMATION RESEARCH (2018)
Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity
D. Wilsmann-Theis et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
S100A8/A9: From basic science to clinical application
Monika Pruenster et al.
PHARMACOLOGY & THERAPEUTICS (2016)
FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
Sofie Van Gassen et al.
CYTOMETRY PART A (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody
Chris B. Russell et al.
JOURNAL OF IMMUNOLOGY (2014)
Monocyte-Induced Development of Th17 Cells and the Release of S100 Proteins Are Involved in the Pathogenesis of Graft-versus-Host Disease
Katharina Reinhardt et al.
JOURNAL OF IMMUNOLOGY (2014)
IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions
Andrew L. Croxford et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
The Pro-Apoptotic and Pro-Inflammatory Effects of Calprotectin on Human Periodontal Ligament Cells
Yunfei Zheng et al.
PLOS ONE (2014)
DAMP Molecule S100A9 Acts as a Molecular Pattern to Enhance Inflammation during Influenza A Virus Infection: Role of DDX21-TRIF-TLR4-MyD88 Pathway
Su-Yu Tsai et al.
PLOS PATHOGENS (2014)
S100A8-S100A9 Protein Complex Mediates Psoriasis by Regulating the Expression of Complement Factor C3
Helia B. Schonthaler et al.
IMMUNITY (2013)
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
David A. Martin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
Stanislav Pantelyushin et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
Astrid B. Van Belle et al.
JOURNAL OF IMMUNOLOGY (2012)
Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis
Mayte Suarez-Farinas et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Hiding under the skin Interleukin-17-producing γδT cells go under the skin?
Burkhard Becher et al.
NATURE MEDICINE (2012)
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Yihua Cai et al.
IMMUNITY (2011)
The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells
Karin Loser et al.
NATURE MEDICINE (2010)
Gene from a Psoriasis Susceptibility Locus Primes the Skin for Inflammation
Ronald Wolf et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits et al.
JOURNAL OF IMMUNOLOGY (2009)
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Rajan P. Nair et al.
NATURE GENETICS (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
Per Bjork et al.
PLOS BIOLOGY (2009)
arrayQualityMetrics—a bioconductor package for quality assessment of microarray data
Audrey Kauffmann et al.
BIOINFORMATICS (2008)
Type I Interferon: Potential Therapeutic Target for Psoriasis?
Yihong Yao et al.
PLOS ONE (2008)
Increased expression of Wnt5a in psoriatic plaques
Joachim Reischl et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis
S. Benoit et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis
Katsue Sunahori et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro
MP Manitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Share Paper
